| 摘要 |
COMPOUNDS OF THE FORMULA 1(FORMULA 1)OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, WHEREIN A AND B ARE 0-2, PROVIDED THAT THE SUM IS 0-3;Q IS =C- OR -N=; I R4 X IS -O-, -S-, -SO-, -SO2-, -CH(OR8)-, -C(O)-, -C(R23)2-, OPTIONALLY SUBSTITUTED ALKENYL, ALKYNYL OR -C- ;R1 IS OPTIONALLY SUBSTITUTED ARYL, HETEROARYL, SUBSTITUTED AMINO,(FORMULA1) WHEREIN M IS 1-4, OR(FORMULA1)WHEREIN D AND E ARE 0-2;R2, R3, R4 AND R5 ARE H, ALKYL, OPTIONALLY SUBSTITUTED CYCLOALKYL, HALOGEN, -OR8-, -N(R8)2, -CO2R8 OR CF3;R6 AND R7 ARE H, ALKYL, ALKENYL, HYDROXYALKYL, AMINOALKYL, ALKOXY-ALKYL, CYCLOALKYL OR CYCLOALKYLALKYL, OR R6 AND R7, FORM A 3-7-MEMBERED CARBOCYCLIC RING, OR A 4-7-MEMBERED HETEROCYCLIC RING;R8 IS H, ALKYL, CYCLOALKYL, OPTIONALLY SUBSTITUTED ARYL OR HETEROARYL;R9 IS ALKYL, CYCLOALKYL, OPTIONALLY SUBSTITUTED ARYL OR HETEROARYL;R11 IS H, ALKYL OR CYCLOALKYL; ANDR23 IS R8 OR HALOGEN;ARE CLAIMED, AS WELLAS ADDITIONAL NOVEL COMPOUNDS; ALSO CLAIMED ARE PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAID NOVEL COMPOUNDS IN THE TREATMENT OF EATING DISORDERS AND DIABETES.
|
